Advanced Search

 

Study ID Status Title Patient Level Data
FLTB3049 Completed A phase III, randomised, double-blind, parallel group study to compare the efficacy of inhaled fluticasone propionate 100mg given once daily and fluticasone propionate 50mg given twice daily, both delivered via the multi-dose powder inhaler, in children aged 4–16 years with mild to…
FLTB3051 Completed Report on a multicentre, randomised, double-blind, parallel-group clinical trial to compare the efficacy and safety of the dry powder formulation of fluticasone proprionate (FP) 200mg/day with fluticasone proprionate 400mg/day administered for 6 weeks from a multidose powder device (Diskus™) to…
FLTB3052 Completed A Multicentre, Randomised, Double-blind, Placebo-controlled, Parallel Group Study Examining the Effect of Fluticasone Propionate Aqueous Nasal Spray (200µg once daily (od)) as an Adjunct to Antibiotic Therapy in Subjects with Recurrent Sinusitis.
FLTB3053 Completed A multicentre, randomised, double-blind, placebo-controlled, parallel group study examining the effect of fluticasone propionate aqueous nasal spray (200µg once daily [od]) as an adjunct to antibiotic therapy in subjects with recurrent sinusitis.
FLTB3054 Completed A multicentre, double-blind, placebo-controlled, parallel group study of the efficacy and tolerability of long-term inhaled fluticasone propionate 500mg twice daily via a Volumatic Spacer device in patients with non-asthmatic chronic obstructive pulmonary disease, including… Study Listed on ClinicalStudyDataRequest.com
FLTB3055 Completed A double blind, double dummy, crossover study to compare the systemic pharmacodynamic effects and safety of inhaled fluticasone propionate Nebules™ 1mg bd with oral prednisolone administered for 7 days to children aged 4 to 16 years with asthma.
FLTB4002 Completed A single centre, randomised, open cross-over study to compare the handling and efficacy of fluticasone propionate 50mcg bd delivered via multi-dose powder inhaler (MDPI) or via Diskhaler in paediatric patients with asthma
FLTB4003 Completed A comparison of the efficacy and tolerability of high dose inhaled fluticasone propionate via a metered-dose inhaler and the Volumatic spacer device with nebulised budesonide in adult asthmatics.
FLTB4009 Completed A Study to Determine the Systemic Activity of a Single Dose of Fluticasone Propionate via the Diskus in Asthmatic Children Inhaling at Different Inspiratory Flows
FLTF3003 Completed A multicentre, randomised, double-blind, parallel group, controlled versus placebo, eight month study, to evaluate efficacy and tolerability of fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis in adults.
Flu-Pan-Meta-Analysis-201109 Completed Integrated summary of the safety of AS03-adjuvanted monovalent H5N1 and H1N1 vaccines in adults 18 years of age and older
FLUPD/AH90/N081 Completed A phase III multicentre, open, parallel-group, randomised study to compare the efficacy and tolerability of fluticasone propionate 50 micrograms bd via the Diskhaler™ with inhaled sodium cromoglycate (Intal) 20 milligrams qds via the Spinhaler in asthmatic children with a clinic requirement for ...
FLUTI/AH89/J78 Completed A phase III, multi-centre, open-label, parallel group study to compare the efficacy and tolerability of fluticasone propionate 500 micrograms bd with budesonide 600 micrograms bd administered via a metered dose inhaler in adult patients with moderate to severe symptomatic asthma.
FLUTI/AH92/N114 Completed A phase III, multi-centre, double-blind, parallel group study to compare the efficacy and tolerability of a high dose step-down treatment regimen of fluticasone propionate (2.0mg reducing to 0.5mg daily) with a fixed dose of fluticasone propionate (0.5mg daily) in maintaining the control achieve ...
FMDT01 Completed A multi-centre, randomised, double-blind, double-dummy, parallel-group study to determine the clinical equivalence between fluticasone propionate 50µg twice daily delivered via a multidose powder inhaler (MDPI) and the Diskhaler™ in children aged 4-11 years with reversible airways disease
FMDT02 Completed A multi-centre, randomised, double-blind, double-dummy, parallel-group study to determine the clinical equivalence between fluticasone propionate 100mg twice daily delivered via a multidose powder inhaler (MDPI) and the Diskhaler™ in adult and paediatric patients with reversible airways disease.
FMDT04 Completed A multi-centre, randomised, double-blind, double-dummy, parallel-group study to determine the clinical equivalence between fluticasone propionate 500µg twice daily delivered via a multidose powder inhaler (MDPI) and the Diskhaler™ in adult patients with moderate to severe reversible airways disease
FMS10001 Completed Fluticasone propionate versus Zafirlukast for the treatment of mild to moderate symptomatic asthma
FMS10002 Completed A Study of the Tolerance of an Increasing Dose of Oral Fluticasone Propionate in a Formulation for Topical Use in Gastrointestinal Disorders
FMS10004 Completed To Investigate the Effect of Single Oral Doses of Fluticasone Propionate (CCI 18781) on Plasma Cortisol Levels
FMS10005 Completed The safety and tolerance of multiple doses of fluticasone propionate taken from a Diskhaler™
FMS10006 Completed Evaluation of the Safety and Tolerance of Multiple Inhaled Doses of Fluticasone Propionate in Healthy Adult Male Volunteers
FMS10008 Completed To Study the Tolerance of Repeated Doses of Inhaled Fluticasone Propionate and Beclomethasone Dipropionate in Divided Daily Doses of Up to 3mg Per Day
FMS10010 Completed Plasma Level Profiles of Fluticasone Propionate After Single Doses From an Aerosol and Dry Powder Presentation
FMS10011 Completed Report of the bioequivalence study comparing three strengths (100, 250 and 500mcg) fluticasone propionate Rotadisks™

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.